非凡中国(08032.HK)前三季纯利升990.5%至9.12亿港元
格隆汇11月12日丨非凡中国(08032.HK)公布,截至2019年9月30日止9个月,集团实现收益4.95亿港元,同比下降43.1%;毛利9255.8万港元,同比下降28.2%;权益持有人应占溢利9.12亿港元,同比增长990.5%;基本每股盈利8.10港仙,不派息。
公告称,收益下降乃主要由于企业策略调整,期内大幅缩减建材销售业务规模所致。集团预料通过专注发展三大业务版块,综合收益将随着三大业务取得稳步成长而逐步改善。
公司权益持有人应占溢利显著升幅主要由于期内出售一间联营公司(李宁公司)的6.8%权益而产生的收益以及分占主要联营公司溢利增加,部分由毛利减少以及行政费用及财务成本增加而抵销。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.